BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22314281)

  • 1. Non-invasive microCT imaging characterization and in vivo targeting of BB2 receptor expression of a PC-3 bone metastasis model.
    Winkelmann CT; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ
    Mol Imaging Biol; 2012 Dec; 14(6):667-75. PubMed ID: 22314281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro and in vivo evaluation of hypoxia-enhanced 111In-bombesin conjugates for prostate cancer imaging.
    Zhou Z; Wagh NK; Ogbomo SM; Shi W; Jia Y; Brusnahan SK; Garrison JC
    J Nucl Med; 2013 Sep; 54(9):1605-12. PubMed ID: 23896558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model.
    Garrison JC; Rold TL; Sieckman GL; Naz F; Sublett SV; Figueroa SD; Volkert WA; Hoffman TJ
    Bioconjug Chem; 2008 Sep; 19(9):1803-12. PubMed ID: 18712899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues.
    Prasanphanich AF; Nanda PK; Rold TL; Ma L; Lewis MR; Garrison JC; Hoffman TJ; Sieckman GL; Figueroa SD; Smith CJ
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12462-7. PubMed ID: 17626788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destruction.
    Johnson LC; Johnson RW; Munoz SA; Mundy GR; Peterson TE; Sterling JA
    Bone; 2011 Jan; 48(1):141-51. PubMed ID: 20685406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
    Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
    J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of combined (177)Lu-DOTA-8-AOC-BBN (7-14)NH(2) GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice.
    Johnson CV; Shelton T; Smith CJ; Ma L; Perry MC; Volkert WA; Hoffman TJ
    Cancer Biother Radiopharm; 2006 Apr; 21(2):155-66. PubMed ID: 16706636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.
    Stott Reynolds TJ; Schehr R; Liu D; Xu J; Miao Y; Hoffman TJ; Rold TL; Lewis MR; Smith CJ
    Nucl Med Biol; 2015 Feb; 42(2):99-108. PubMed ID: 25459113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog.
    Dijkgraaf I; Franssen GM; McBride WJ; D'Souza CA; Laverman P; Smith CJ; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2012 Jun; 53(6):947-52. PubMed ID: 22570329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells.
    Smith CJ; Gali H; Sieckman GL; Hayes DL; Owen NK; Mazuru DG; Volkert WA; Hoffman TJ
    Nucl Med Biol; 2003 Feb; 30(2):101-9. PubMed ID: 12623108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.
    Raheem O; Kulidjian AA; Wu C; Jeong YB; Yamaguchi T; Smith KM; Goff D; Leu H; Morris SR; Cacalano NA; Masuda K; Jamieson CH; Kane CJ; Jamieson CA
    J Transl Med; 2011 Oct; 9():185. PubMed ID: 22035283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of Prostate Cancer Bone Metastasis.
    Park SH; Eber MR; Shiozawa Y
    Methods Mol Biol; 2019; 1914():295-308. PubMed ID: 30729472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model.
    Fritz V; Louis-Plence P; Apparailly F; Noël D; Voide R; Pillon A; Nicolas JC; Müller R; Jorgensen C
    Bone; 2007 Apr; 40(4):1032-40. PubMed ID: 17251073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of a novel ¹¹¹In-labeled bombesin homodimer for improved imaging of GRPR-positive prostate cancer.
    Carlucci G; Ananias HJ; Yu Z; Hoving HD; Helfrich W; Dierckx RA; Liu S; de Jong IJ; Elsinga PH
    Mol Pharm; 2013 May; 10(5):1716-24. PubMed ID: 23590837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice.
    Cowey S; Szafran AA; Kappes J; Zinn KR; Siegal GP; Desmond RA; Kim H; Evans L; Hardy RW
    Clin Exp Metastasis; 2007; 24(5):389-401. PubMed ID: 17541709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model.
    Ravoori M; Czaplinska AJ; Sikes C; Han L; Johnson EM; Qiao W; Ng C; Cody DD; Murphy WA; Do KA; Navone NM; Kundra V
    PLoS One; 2010 Mar; 5(3):e9854. PubMed ID: 20360964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.
    Rogers BE; Bigott HM; McCarthy DW; Della Manna D; Kim J; Sharp TL; Welch MJ
    Bioconjug Chem; 2003; 14(4):756-63. PubMed ID: 12862428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.
    Hoffman TJ; Gali H; Smith CJ; Sieckman GL; Hayes DL; Owen NK; Volkert WA
    J Nucl Med; 2003 May; 44(5):823-31. PubMed ID: 12732685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone metastasis imaging with SPECT/CT/MRI: a preclinical toolbox for therapy studies.
    Sanches PG; Peters S; Rossin R; Kaijzel EL; Que I; Löwik CW; Grüll H
    Bone; 2015 Jun; 75():62-71. PubMed ID: 25680341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.